MULTIPLYING THE POSSIBILITIES Trademark

Trademark Overview


On Thursday, March 28, 2024, a trademark application was filed for MULTIPLYING THE POSSIBILITIES with the United States Patent and Trademark Office. The USPTO has given the MULTIPLYING THE POSSIBILITIES trademark a serial number of 98473700. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, October 10, 2024. This trademark is owned by CAPSTAN THERAPEUTICS, INC.. The MULTIPLYING THE POSSIBILITIES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals; pharmaceutical preparations; pharmaceutical substances; therapeutics; therapeutic agents; systems to express therapeutic proteins in vivo; biopharmaceuticals; medicines; drugs; vaccines; in vivo cell therapies; cells for medical or clinical use; stem cells for medical purposes; cells for medical use; genetically engineered cells; gene therapy products; gene therapy preparations; gene therapy products, namely, genetically engineered cells for transplant purposes; targeted in vivo RNA technologies; targeted lipid nanoparticles for medicinal use; targeted lipid nanoparticles for durable cell reprogramming or cell engineering; targeted lipid nanoparticles for transient cell reprogramming or cell engineering; cell engineering platforms; cell platforms for treatment of human diseases, disorders and conditions; technology platforms for developing and engineering therapeutic cells; in vivo cell engineering platforms; transient in vivo cell engineering platforms for durable gen...
multiplying the possibilities

General Information


Serial Number98473700
Word MarkMULTIPLYING THE POSSIBILITIES
Filing DateThursday, March 28, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, October 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals; pharmaceutical preparations; pharmaceutical substances; therapeutics; therapeutic agents; systems to express therapeutic proteins in vivo; biopharmaceuticals; medicines; drugs; vaccines; in vivo cell therapies; cells for medical or clinical use; stem cells for medical purposes; cells for medical use; genetically engineered cells; gene therapy products; gene therapy preparations; gene therapy products, namely, genetically engineered cells for transplant purposes; targeted in vivo RNA technologies; targeted lipid nanoparticles for medicinal use; targeted lipid nanoparticles for durable cell reprogramming or cell engineering; targeted lipid nanoparticles for transient cell reprogramming or cell engineering; cell engineering platforms; cell platforms for treatment of human diseases, disorders and conditions; technology platforms for developing and engineering therapeutic cells; in vivo cell engineering platforms; transient in vivo cell engineering platforms for durable gene therapy;

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 28, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCAPSTAN THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Thursday, March 28, 2024NEW APPLICATION ENTERED
Thursday, March 28, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 9, 2024ASSIGNED TO EXAMINER
Thursday, October 10, 2024NON-FINAL ACTION E-MAILED
Thursday, October 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 10, 2024NON-FINAL ACTION WRITTEN
Tuesday, April 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED